NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
Support NHLBI Intramural researchers transitioning to independent investigators at external institutions via K22 grant funding.
Funder: National Institutes of Health
Due Dates: June 12, 2025 (New) | July 12, 2025 (Renewal/Resubmission) | October 12, 2025 (New) | November 12, 2025 (Renewal/Resubmission) | February 12, 2026 (New) | March 12, 2026 (Renewal/Resubmission) | June 12, 2026 (New) | July 12, 2026 (Renewal/Resubmission) | October 12, 2026 (New) | November 12, 2026 (Renewal/Resubmission) | February 12, 2027 (New) | March 12, 2027 (Renewal/Resubmission) | June 12, 2027 (New) | July 12, 2027 (Renewal/Resubmission)
Funding Amounts: Up to 2 years intramural support (NHLBI salary structure) plus up to 3 years extramural support (max $249,000/year total costs; $747,000 total for extramural phase; 8% F&A rate)
Summary: Supports NHLBI intramural postdoctoral fellows and research trainees transitioning to independent research positions at external institutions; independent clinical trials are not allowed.
Key Information: Only current NHLBI intramural postdocs/trainees are eligible; transition to extramural phase requires NHLBI approval and a tenure-track (or equivalent) offer.
Description
This opportunity provides a structured pathway for highly qualified postdoctoral fellows and other doctoral-level researchers currently in training within the NHLBI Division of Intramural Research to transition to independent research careers at extramural (non-NIH) institutions. The award consists of two phases: a mentored intramural phase (up to 2 years) at NHLBI, followed by an independent extramural phase (up to 3 years) at an external institution. The program is designed to facilitate the establishment of a record of independent research and to support the development of junior investigators in heart, lung, blood, and sleep research fields.
Note: This funding opportunity does not allow applicants to lead independent clinical trials, but research experience in a clinical trial led by a mentor/co-mentor is permitted.
